What's Happening?
Startup MoldCo has received $8 million in seed funding to expand its virtual clinic services for mold-related illnesses. The funding, co-led by Cantos and Collaborative Fund, aims to enhance MoldCo's lab testing and treatment services. MoldCo was founded by Ariana Thacker, who experienced severe health issues due to mold exposure in her Miami apartment. The company offers telehealth services, providing access to specialists and testing for mold toxicity. MoldCo plans to expand its services nationwide by 2026, aiming to make mold detox a routine part of preventive care.
Why It's Important?
Mold exposure is a significant health issue affecting millions in the U.S., often leading to chronic conditions. MoldCo's virtual clinic addresses accessibility barriers, offering specialized care and testing for mold toxicity. The company's expansion could improve diagnosis and treatment for mold-related illnesses, potentially reducing healthcare costs and improving patient outcomes. With over 50% of U.S. households showing signs of mold, MoldCo's services could fill a critical gap in healthcare, providing relief to those suffering from mold exposure.
What's Next?
MoldCo plans to expand its virtual clinic services nationwide by 2026, further developing its proprietary care technology and scaling patient onboarding. The company aims to standardize mold detox as a routine part of preventive care, increasing public and physician awareness of mold toxicity. MoldCo is also working on introducing an ICD-10 code for mold-related illness to improve diagnosis and treatment accessibility. The company will continue to invest in clinical research collaborations to enhance its services.
